(Q28139426)

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

Histologic grading of prostate cancer: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

Multiblock: an aid in diagnostic immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

Demonstration of the prostatic origin of metastases.An immunohistochemical method for formalin-fixed embedded tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

Anti-Leu 7 immunoreactivity with human tumours: its value in the diagnosis of prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

The natural-killer-cell-associated HNK-1 (Leu-7) antibody reacts with hypertrophic and malignant prostatic epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

Monoclonal antibody (anti-Leu 7) directed against natural killer cells reacts with normal, benign and malignant prostate tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

Identification of p53 gene mutations in bladder cancers and urine samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

Prostatic involvement in bladder cancer. Prostate mapping in 20 cystoprostatectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Immunohistochemical demonstration of prostatic origin of metastases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Multiple Immunoperoxidase Markers in Benign Hyperplasia and Adenocarcinoma of the Prostate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Immunoperoxidase localization of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Anticytokeratin antibody 34 beta E12 staining in prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Reactivity of B72.3 with adenocarcinomas. An immunohistochemical study of 476 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Prostatic adenocarcinoma. Evaluation of immunoreactivity to monoclonal antibody B72.3.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Expression of Leu-M1 antigens in carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Carcinoembryonic antigen localization in benign and malignant transitional epithelium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880220

7 January 2021